Yabao Pharmaceutical Group Co., Ltd (SHA:600351)

China flag China · Delayed Price · Currency is CNY
7.08
+0.16 (2.31%)
Apr 30, 2026, 3:00 PM CST
18.00%
Market Cap 4.79B
Revenue (ttm) 2.20B
Net Income (ttm) 319.41M
Shares Out 692.00M
EPS (ttm) 0.46
PE Ratio 15.08
Forward PE n/a
Dividend 0.40 (5.79%)
Ex-Dividend Date Feb 6, 2026
Volume 35,375,634
Average Volume 26,861,476
Open 6.88
Previous Close 6.92
Day's Range 6.85 - 7.10
52-Week Range 5.86 - 8.68
Beta 0.11
RSI 59.46
Earnings Date Apr 25, 2026

About SHA:600351

Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Beijing, China. [Read more]

Sector Healthcare
Founded 1978
Employees 3,611
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600351
Full Company Profile

Financial Performance

In 2025, SHA:600351's revenue was 2.24 billion, a decrease of -16.60% compared to the previous year's 2.69 billion. Earnings were 320.01 million, an increase of 31.86%.

Financial Statements

News

There is no news available yet.